Abstract
Clostridium difficile infection (CDI) remains a considerable challenge to health care systems worldwide. Although CDI represents a significant burden on healthcare systems in Europe, few studies have attempted to estimate the consumption of resources associated with CDI in Europe. The reported extra costs attributable to CDI vary widely according to the definitions, design, and methodologies used, making comparisons difficult to perform. In this chapter, the economic burden of healthcare facility–associated CDI in Europe will be assessed, as will other less explored areas such as the economic burden of recurrent CDI, community-acquired CDI, pediatric CDI, and CDI in outbreaks.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Eidan FA, McElnay JC, Scott MG, Kearney MP (2000) Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther 25(2):101–109
Asensio A, Bouza E, Grau S, Rubio-Rodriguez D, Rubio-Terres C (2013) Cost of Clostridium difficile associated diarrhea in Spain. Rev Esp Salud Publica 87(1):25–33. https://doi.org/10.4321/s1135-57272013 000100004
Asensio A, Di Bella S, Lo Vecchio A, Grau S, Hart WM, Isidoro B, Scotto R, Petrosillo N, Watt M, Nazir J (2015) The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study. Int J Infect Dis 36:31–38. https://doi.org/10.1016/j.ijid.2015.05.013
Barbut F (2015) How to eradicate Clostridium difficile from the environment. J Hosp Infect 89(4):287–295. https://doi.org/10.1016/j.jhin.2014.12.007
Barbut F, Jones G, Eckert C (2011) Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis 24(4):370–376. https://doi.org/10.1097/QCO.0b013e32 834748e5
Bouza E (2012) Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect 18(Suppl 6):5–12. https://doi.org/10.1111/1469-0691.12064
Dubberke ER, Olsen MA (2012) Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55(Suppl 2):S88–S92. https://doi.org/10.1093/cid/cis335
Eckmann C, Wasserman M, Latif F, Roberts G, Beriot-Mathiot A (2013) Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries. Eur J Health Econ 14(5):835–846
Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23(3):529–549. https://doi.org/10.1128/cmr.00082-09
Gabriel L, Beriot-Mathiot A (2014) Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. J Hosp Infect 88(1):12–21. https://doi.org/10.1016/j.jhin.2014.04.011
Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW (2010) Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 74(4):309–318. https://doi.org/10.1016/j.jhin.2009.10.016
Grube RF, Heinlein W, Scheffer H, Rathmayer M, Schepp W, Lohse AW, Stallmach A, Wilke MH, Lerch MM (2015) Economic burden of Clostridium difficile enterocolitis in German hospitals based on routine DRG data. Z Gastroenterol 53(5):391–397. https://doi.org/10.1055/s-0034-1398803
Hubner C, Hubner NO, Muhr M, Claus F, Leesch H, Kramer A, Flessa S (2015) Cost analysis of hospitalized Clostridium difficile-associated diarrhea (CDAD). GMS Hyg Infect Control 10:Doc13. https://doi.org/10.3205/dgkh000256
Jones AM, Kuijper EJ, Wilcox MH (2013) Clostridium difficile: a European perspective. J Inf Secur 66(2):115–128. https://doi.org/10.1016/j.jinf.2012.10.019
Kuijper EJ, Coignard B, Tull P (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):2–18. https://doi.org/10.1111/j.1469-0691.2006.01580.x
Kulaylat AN, Rocourt DV, Podany AB, Engbrecht BW, Twilley M, Santos MC, Cilley RE, Hollenbeak CS, Dillon PW (2017) Costs of Clostridium difficile infection in pediatric operations: a propensity score-matching analysis. Surgery 161(5):1376–1386. https://doi.org/10.1016/j.surg.2016.10.020
Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH (2012) Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol 33(10):1031–1038. https://doi.org/10.1086/667733
Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, Frederick J, Evans S, Engel J, McDonald LC (2010) Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 16(2):197–204. https://doi.org/10.3201/eid1602.090953
Le Monnier A, Duburcq A, Zahar JR, Corvec S, Guillard T, Cattoir V, Woerther PL, Fihman V, Lalande V, Jacquier H, Mizrahi A, Farfour E, Morand P, Marcade G, Coulomb S, Torreton E, Fagnani F, Barbut F (2015) Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals. J Hosp Infect 91(2):117–122. https://doi.org/10.1016/j.jhin.2015.06.017
McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY (2012) The economic burden of Clostridium difficile. Clin Microbiol Infect 18(3):282–289. https://doi.org/10.1111/j.1469-0691.2011.03571.x
Mitchell BG, Gardner A (2012) Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control 1(1):14. https://doi.org/10.1186/2047-2994-1-14
Nanwa N, Kendzerska T, Krahn M, Kwong JC, Daneman N, Witteman W, Mittmann N, Cadarette SM, Rosella L, Sander B (2015) The economic impact of Clostridium difficile infection: a systematic review. Am J Gastroenterol 110(4):511–519. https://doi.org/10.1038/ajg.2015.48
Nanwa N, Sander B, Krahn M, Daneman N, Lu H, Austin PC, Govindarajan A, Rosella LC, Cadarette SM, Kwong JC (2017) A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions. PLoS One 12(3):e0172410. https://doi.org/10.1371/journal.pone.0172410
Nasr A, Reichardt K, Fitzgerald K, Arumugusamy M, Keeling P, Walsh TN (2004) Impact of emergency admissions on elective surgical workload. Ir J Med Sci 173(3):133–135
Pillai DR, Longtin J, Low DE (2010) Surveillance data on outbreaks of Clostridium difficile infection in Ontario, Canada, in 2008–2009. Clin Infect Dis 50(12):1685–1686. https://doi.org/10.1086/653007. author reply 1686
Poli A, Di Matteo S, Bruno GM, Fornai E, Valentino MC, Colombo GL (2015) Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy. Risk Manag Healthc Policy 8:207–213. https://doi.org/10.2147/rmhp.s90513
Robb WB, O’Sullivan MJ, Brannigan AE, Bouchier-Hayes DJ (2004) Are elective surgical operations cancelled due to increasing medical admissions? Ir J Med Sci 173(3):129–132
Ryan P, Skally M, Duffy F, Farrelly M, Gaughan L, Flood P, McFadden E, Fitzpatrick F (2017) Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research. J Hosp Infect 95(4):415–420. https://doi.org/10.1016/j.jhin.2017.01.016
Sammons JS, Localio R, Xiao R, Coffin SE, Zaoutis T (2013) Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 57(1):1–8. https://doi.org/10.1093/cid/cit155
Singer AJ, Thode HC Jr, Viccellio P, Pines JM (2011) The association between length of emergency department boarding and mortality. Acad Emerg Med 18(12):1324–1329. https://doi.org/10.1111/j.1553-2712.2011.01236.x
Van Beurden YH, Bomers MK, van der Werff SD, Pompe EA, Spiering S, Vandenbroucke-Grauls CM, Mulder CJ (2017) Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre. J Hosp Infect 95(4):421–425. https://doi.org/10.1016/j.jhin.2016.12.019
Van Kleef E, Green N, Goldenberg SD, Robotham JV, Cookson B, Jit M, Edmunds WJ, Deeny SR (2014) Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach. J Hosp Infect 88:213–217
VerLee KE, Finks JL, Wilkins MJ, Wells EV (2012) Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002–2008. Public Health Rep 127(1):62–71
Vonberg RP, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P (2008a) Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 70(1):15–20. https://doi.org/10.1016/j.jhin.2008.05.004
Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S (2012) Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 81(1):1–14. https://doi.org/10.1016/j.jhin.2012.02.004
Wilcox MH, Cunniffe JG, Trundle C, Redpath C (1996) Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34(1):23–30
Wilcox MH, Ahir H, Coia JE, Dodgson A, Hopkins S, Llewelyn MJ, Settle C, McLain-Smith S, Marcella SW (2017) Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life. J Antimicrob Chemother 72:2647–2656. https://doi.org/10.1093/jac/dkx174
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Reigadas Ramírez, E., Bouza, E.S. (2018). Economic Burden of Clostridium difficile Infection in European Countries. In: Mastrantonio, P., Rupnik, M. (eds) Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology(), vol 1050. Springer, Cham. https://doi.org/10.1007/978-3-319-72799-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-72799-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72798-1
Online ISBN: 978-3-319-72799-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)